Loading organizations...
§ Private Profile · 632 Broadway Fl 5, New York City, New York, 10012, United States
Symbiont is a company.
Symbiont has raised $21.3M across 2 funding rounds.
Key people at Symbiont.
Symbiont was founded in 2013 by Adam Krellenstein (Co-Founder, CTO, Chief Scientist).
Symbiont has raised $21.3M in total across 2 funding rounds.
Symbiont develops an enterprise blockchain platform leveraging smart contracts to enhance efficiency and transparency within financial markets. Its core offering provides a distributed ledger technology solution designed to automate complex financial agreements, reduce operational risk, and streamline data reconciliation for institutional participants. The platform facilitates digital asset creation and execution of contractual obligations in capital markets.
Symbiont was co-founded by Mark Smith, Adam Krellenstein, Evan Wagner, and Robby Dermody. Mark Smith, a veteran in capital markets with prior experience building and exiting a financial institution, initiated the company. Their collective insight focused on blockchain technology's potential to address long-standing challenges in financial services, leading to its enterprise establishment.
The company primarily serves institutional financial clients, including asset managers and banks, seeking to modernize back-office operations and implement digital asset strategies. Symbiont’s vision is to establish a more transparent, efficient, and resilient global financial ecosystem by providing secure, scalable blockchain infrastructure, supporting the evolution of financial instruments and reshaping value exchange.
Symbiont has raised $21.3M across 2 funding rounds. Most recently, it raised $20.0M Series B in January 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 23, 2019 | $20M Series B | Nasdaq Ventures | Citi, Galaxy Digital, Raptor Group | Announced |
| Jun 9, 2015 | $1.3M Seed | — | Duncan L. Niederauer, Matt Andresen, Scott Carmilani, Celeridem Fintech Fund, Stephen Schuler | Announced |
Key people at Symbiont.
Symbiont is an enterprise blockchain technology company that developed smart contract platforms and distributed ledger solutions primarily for capital markets and financial services[1][2][5]. Its core product, such as the Assembly platform, enabled institutional applications like smart securities, loans, swaps, and records, serving financial institutions, governments, and insurers to streamline processes, enhance transparency, and reduce risks[1][3][5]. The company addressed inefficiencies in legacy financial systems by providing interfaces for issuing smart securities integrated with market data feeds, with clients including Vanguard, the State of Delaware, Credit Suisse, and Medici Ventures[1][2][3]. Founded in 2013 in New York, Symbiont raised between $15.4M and $28.93M before facing challenges, filing for bankruptcy in early 2023, and being acquired by Platonic Holdings in December 2023, marking a shift from high-growth innovator to acquired asset amid blockchain market turbulence[1][2].
Symbiont was founded in 2013 (with some sources noting 2015) in New York by a team of capital markets experts and blockchain engineers, aiming to bring distributed ledger technology to institutional finance[1][2][3]. The idea emerged from recognizing blockchain's potential to automate complex financial instruments via smart contracts, enabling full lifecycle management on decentralized networks with privacy features[2][5]. Early traction came through partnerships like its joint venture Synaps with Ipreo for smart loans used by 19 financial institutions arranged by Credit Suisse, Smart Records for the State of Delaware, and Smart Swaps for a major European insurer[3]. Strategic investments, such as from Medici Ventures in 2017, fueled growth and collaborations on projects like blockchain-based fund administration, but by 2023, asset sales and bankruptcy amid industry headwinds led to its acquisition by Platonic Holdings[1][2][3].
(Note: A separate entity, Symbiont Ventures in San Antonio, focuses on general high-growth investments and is unrelated to this blockchain firm[4].)
Symbiont rode the early 2010s blockchain wave in finance, capitalizing on post-2008 demands for transparent, efficient alternatives to legacy systems amid rising interest in tokenization and DLT for capital markets[1][2][3]. Its timing aligned with regulatory explorations (e.g., Delaware's blockchain records) and institutional pilots, influencing the shift toward smart contracts in loans, securities, and insurance, which paved the way for modern DeFi and RWA (real-world asset) trends[3][5]. Market forces like cost pressures in reconciliation and settlement favored its solutions, helping legitimize enterprise blockchain against hype-driven failures; however, broader crypto winters and bankruptcies highlighted scalability risks, with Symbiont's 2023 acquisition underscoring consolidation in fintech DLT[1][2]. It contributed to the ecosystem by proving blockchain's viability for incumbents, inspiring competitors like Digital Asset and Provenance, and accelerating hybrid on-chain/off-chain infrastructures still shaping global market infrastructure[1].
Under Platonic Holdings since late 2023, Symbiont's technology likely integrates into broader fintech or blockchain portfolios, potentially reviving its smart contract tools for tokenized assets amid maturing RWA markets and regulatory clarity[1]. Trends like institutional tokenization, CBDCs, and AI-blockchain convergence could drive resurgence, especially if Platonic leverages its IP for capital markets efficiency. Its influence may evolve from pioneer to foundational tech in acquired form, underscoring blockchain's path from disruption to embedded infrastructure—echoing its original mission to redefine financial ledgers for the digital era[2][5].
Symbiont was founded in 2013 by Adam Krellenstein (Co-Founder, CTO, Chief Scientist).
Symbiont has raised $21.3M in total across 2 funding rounds.
Symbiont's investors include Nasdaq Ventures, Citi, Galaxy Digital, Raptor Group, Duncan L. Niederauer, Matt Andresen, Scott Carmilani, Celeridem FinTech Fund, Stephen Schuler.
